Reliability and Validity of the Six-Spot Step Test After Total Hip Arthroplasty

NCT06704217 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2025-01-14

No results posted yet for this study

Summary

This study aims to assess the SSST's validity, reliability, and ability to differentiate between high and low fall risk individuals in THA patients. Establishing the SSST as a valid and reliable tool will help manage rehabilitation and apply timely interventions for THA patients.

Conditions

  • Total Hip Replacement
  • Reproducibility of Results
  • Rehabilitation

Interventions

DIAGNOSTIC_TEST

Six Spot Step Test

The Six-Spot Step Test (SSST), which evaluates balance and functional ambulation, will be performed in an area 5 meters long and 1 meter wide. Five wooden cylinders will be arranged in a zig-zag pattern within this space, with the last cylinder positioned at the centerline. The participant will be asked to strike the wooden cylinders with the medial or lateral side of the same foot and push them outward. The test will be repeated twice with the dominant foot and twice with the non-dominant foot. A trial will be conducted before the test to familiarize participants with the procedure. A two-minute rest period between the test and trials will be provided to minimize fatigue effects. The test's inter-rater reliability will be assessed by two physiotherapists with more than 5 years of clinical experience, who will administer the test twice at 5-minute intervals.

DIAGNOSTIC_TEST

Oxford Hip Score

The Oxford Hip Score will be used for functional level assessment.

DIAGNOSTIC_TEST

Berg Balance Scale

The Berg Balance Scale (BBS) will be used to assess dynamic balance, which is reliable and commonly used within the orthopedic setting.

Sponsors & Collaborators

  • T.C. ORDU ÜNİVERSİTESİ

    lead OTHER

Principal Investigators

  • Elif AYGUN POLAT, PhD · T.C. ORDU ÜNİVERSİTESİ

  • Yusuf POLAT, Assoc. Prof. · T.C. ORDU ÜNİVERSİTESİ

  • Sevim ACAROZ, Assoc. Prof. · T.C. ORDU ÜNİVERSİTESİ

  • Yunus Emre OZBILEN, MD · T.C. ORDU ÜNİVERSİTESİ

  • Alper ÇIRAKLI, Prof. · T.C. ORDU ÜNİVERSİTESİ

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-30
Primary Completion
2024-12-30
Completion
2025-01-12

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06704217 on ClinicalTrials.gov